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Abstract: OBJECTIVE: To assess the adoption of recommendation from randomized clinical trials
(RCTs) and investigate factors favoring or preventing adoption. BACKGROUND: RCT are consid-
ered to be the cornerstone of evidence-based medicine by representing the highest level of evidence. As
such, we expect RCT’s recommendations to be followed rigorously in daily surgical practice. METHODS:
We performed a structured search for RCTs published in the medical and surgical literature from 2009
to 2013, allowing a minimum of 5-year follow-up to convincingly test implementation. We focused on
comparative technical or procedural RCTs trials addressing the domains of general, colorectal, hepatobil-
iary, upper gastrointestinal and vascular surgery. In a second step we composed a survey of 29 questions
among ESA members as well as collaborators from their institutions to investigate the adoption of sur-
gical RCTs recommendation. RESULTS: The survey based on 36 RCTs (median 5-yr citation index 85
(24-474), from 21 different countries, published in 15 high-ranked journals with a median impact factor
of 3.3 (1.23-7.9) at the time of publication. Overall, less than half of the respondents (47%) appeared
to adhere to the recommendations of a specific RCT within their field of expertise, even when included
in formal guidelines. Adoption of a new surgical practice was favored by watching videos (46%) as well
as assisting live operations (18%), while skepticism regarding the methodology of a surgical RCT (40%)
appears to be the major reason to resist adoption. CONCLUSION: In conclusion, surgical RCTs appear
to have moderate impact on daily surgical practice. While RCTs are still accepted to provide the highest
level of evidence, alternative methods of evaluating surgical innovations should also be explored.
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Objective: To assess the adoption of recommendation from randomized
clinical trials (RCTs) and investigate factors favoring or preventing adoption.
Background: RCT are considered to be the cornerstone of evidence-based
medicine by representing the highest level of evidence. As such, we expect
RCT’s recommendations to be followed rigorously in daily surgical practice.
Methods: We performed a structured search for RCTs published in the
medical and surgical literature from 2009 to 2013, allowing a minimum of
5-year follow-up to convincingly test implementation. We focused on com-
parative technical or procedural RCTs trials addressing the domains of
general, colorectal, hepatobiliary, upper gastrointestinal and vascular surgery.
In a second step we composed a survey of 29 questions among ESA members
as well as collaborators from their institutions to investigate the adoption of
surgical RCTs recommendation.
Results: The survey based on 36 RCTs (median 5-yr citation index 85 (24–
474), from 21 different countries, published in 15 high-ranked journals with a
median impact factor of 3.3 (1.23–7.9) at the time of publication. Overall, less
than half of the respondents (47%) appeared to adhere to the recommenda-
tions of a specific RCTwithin their field of expertise, even when included in
formal guidelines. Adoption of a new surgical practice was favored by
watching videos (46%) as well as assisting live operations (18%), while
skepticism regarding the methodology of a surgical RCT (40%) appears to be
the major reason to resist adoption.
Conclusion: In conclusion, surgical RCTs appear to havemoderate impact on
daily surgical practice. While RCTs are still accepted to provide the highest
level of evidence, alternative methods of evaluating surgical innovations
should also be explored.
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E vidence-based medicine is the conscientious, explicit, and judi-cious use of current best evidence in making decisions about the
care of individual patients.1,2 Practicing evidence-based medicine
implies integrating individual clinical expertise with the best avail-
able external clinical evidence from systematic research and with
patients’ values, preferences, and expectations.3 Randomized con-
trolled trials (RCTs) have become the cornerstone of modern clinical
research in medicine as they represent the highest level of scientific
evidence presently available.4
Surgeons have been accused of lagging behind their medical
colleagues in embracing evidence-based medicine, as surgical RCTs
reportedly accounted for only 3% to 7% of surgical articles pub-
lished.5–8 A comparison between 4 leading surgical versus medical
journals over a 2-year period revealed a 5-fold higher number of
medical RCTs in the latter compared with surgical trials.9 In addi-
tion, up to 40% of surgical patients were observed not to receive
evidence-based care.10,11 And although there has been a noticeable
improvement in the quantity and quality of published surgical studies
in recent years, widespread practice of evidence-based surgery
remains still modest at best.10,12,13
Proposed reasons for the relative paucity of RCTs from the
surgical disciplines include problematic randomization resulting
from surgeon and patient preferences; that is unbalanced equipoise,
difficulties in reducing bias including the difficulty of blinding or
standardization of procedures, and the rapid pace of changes tech-
niques rendering outcomes of lengthy RCTs irrelevant by the time of
their publication.14 Today, surgical RCTs are discontinued in up to
43%,15 mainly because of slow recruiting, inability of the trial to
achieve its objectives, administrative problems, and costs.15,16
Surprisingly, little is known about the clinical adoption of
available information gathered from surgical RCTs that have over-
come all these hurdles and were eventually published. One would
expect surgical practice to rigorously follow the results of level 1
evidence trial. Hints exist that this might not be the case due to many
factors such as surgeons’ reluctance to change, ignorance, or even ego-
related issues. In fact, examples of RCT evidence exist that convinc-
ingly oppose current clinical practice, but appear unable to change
surgical policy. In vascular surgery, for instance, EndoVascular Aneu-
rysm Repair (EVAR) has been proven to reduce short-term mortality
and morbidity while long-term results appear to be similar and cost
effectiveness is being seriously questioneddue to high cost ofmaterials
and high reintervention rates. Still, EVAR is used in up to 80% of all
elective patients with an abdominal aneurysm.17
The aim of this special article was to assess the impact of
high-quality RCTs in surgery and the adoption of RCToutcomes in
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daily surgical practice. To this end, a systematic evaluation of
procedural surgical RCTs was carried out, followed by a survey
amongmembers of the European Surgical Association in an attempt
to understand the underlying factors preventing adoption of high
level of evidence information.
METHODS
We performed a structured search for RCTs published in the
medical and surgical literature from 2009 to 2013 by screening RCTs
in EMBASE (11,752) and Medline (22,723) using the search terms
(RCT, surgery, surgical device). This period was chosen in order to
ascertain a minimum of 5-year follow-up, allowing sufficient time
for dissemination of the published results into surgical practice, as
well as finding their way into clinical guidelines.We focused on trials
addressing the domains of general (mostly parietology), colorectal,
hepatobiliary, upper gastrointestinal and vascular surgery. Only
comparative technical or procedural RCTs were selected that pro-
duced statistically significantly different results that advocate a
specific procedure or procedural change. Excluded were pilot stud-
ies, RCTs on drug efficacy or investigating training results, as well as
cost effectiveness studies and RCTs which treated the same topic
during the investigated time period, but with contradictory outcomes.
Next, the selected RCTs underwent a qualitative assessment as
to their risk of bias. Most of these RCTs lack a structured reporting
according to CONSORT NTP (Consolidated Standards of Reporting
Trials assessing nonpharmacologic treatment),18,19 which implied a
lack in reporting quality. To determine the internal validity of the
selected trials, the RCTs were further assessed using the Cochrane
criteria for judging risk of bias,20 including random sequence
generation, allocation concealment, blinding of participants and
personnel, as well as blinding of outcome assessment. The intention
was to solely include RCTs with low risk of bias (Fig. 1 and Table 1).
We composed a survey of 22 questions (Addendum 1, http://
links.lww.com/SLA/B749) addressing a selection of 36 representa-
tive RCTs (Addendum 2, http://links.lww.com/SLA/B749) in the
field of general (6 questions), colorectal (7 questions), HPB (6
questions), upper GI (2 questions), and vascular surgery (1 question).
The recommendations of 14 (39%) of these RCTs had been incor-
porated into some guidelines. Moreover, 7 questions relating to the
reasons for surgeons’ adoption or dismissal of RCTs’ recommenda-
tions were included in the survey (Addendum 1: online Survey
questions, http://links.lww.com/SLA/B749). This questionnaire
was first tested on 48 surgeons practicing in academic and nonaca-
demic centers in Switzerland. Following several adaptations in the
phrasing of the questions, it was distributed among 300 members of
the European Surgical Association via the online questionnaire tool
SurveyMonkey.com. Moreover, ESA members and coauthors of this
collaborative work circulated the questionnaire among 10 colleagues
in their respective institutions. Respondents were encouraged not to
address issues that they considered outside their field of expertise. All
replies were analyzed to identify the degree of adherence to the
recommendations of the respective RCTs.
Statistical Analysis
For each of the 22 questions the percentage of answers
corresponding to the respective RCT’s recommendation was deter-
mined. To evaluate possible parameters influencing surgeons’ accep-
tance of the results of RCTs (‘‘corresponding answer"), a linear
regression model was fitted with the proportion of ‘‘corresponding’’
answers as the dependent variable and correlated with the domain of
surgery, year of RCT publication, impact factor of the journal at the
time of publication, 5-year citation index, number of included centers
and total cohort size in each study, as well as the admission of RCT
results into a guideline. In a second step, we also added gender,
surgical specialty, and years of experience after board certification
into the model. The goodness-of-fit of the model was expressed by
R2, P values  0.05 were considered statistically significant. For all
statistical analyses, the program R was used.21
RESULTS
After screening 34,475 RCTs, we identified 2199 trials in the
field of surgery (6.4%) (Fig. 1), which were published in recognized
journals benefiting from an Impact Factor. Further selection
restricted the study to only comparative technical or procedural
RCTs in the domains described above, leaving 506 eligible trials,
of which 219 produced results that were statistically different
between treatment/procedure groups. Robustness evaluation regard-
ing randomization and blinding resulted in a final delineation of 112
RCTs that could be incorporated into our questionnaire (Fig. 1).
These RCTs originated from 30 different countries and were pub-
lished in 15 surgical journals (Annals of Surgery 18 (16%); British
Journal of Surgery 15 (13%); Surgical Endoscopy 12 (10%); Dis-
eases of the Colon and Rectum 7 (6%); World Journal of Surgery 7
(6%); others 53 (47%)). The median 5-year citation index was 54
(range 3–474) and the cohort size of patients included into the RCTs
was 100 (range 24–1000). Most (67%) of the RCTs were conducted
in 1 single center (range 1–41) (Table 1). Out of these RCTs, we
build our questionnaire including 36 RCTs. The selection of RCTs
was done using a pragmatic approach. Based on the frequency of
RCTs of the respective surgical domain, we chose RCTs covering
topics likely encountered in daily practice and added to them a few
specialized questions for each surgical domain. Those RCTs were
comparable with the 112 RCTs regarding Journals of publication,
Impact factor, as well as Citation Index.
Our internationally conducted survey on surgeons’ adoption
of RCT recommendations included 22 questions on abdominal and
vascular surgery, based on 36 RCTs (median 5-yr citation index (CI)
85 (24–474), from 21 different countries, published in 15 high-
ranked journals with amedian impact factor (IF) of 3.3 (1.23–7.9) at
the time of publication. Hundred and thirty international surgeons
(34.2%) completed the survey, 82% of whom were male. The
median surgical expertise after board certification was 16 years
(range 1–48). Among the respondents were 27% general surgeons,
22% colorectal surgeons, 22% hepato-pancreatico-biliary surgeons,
13% upper gastrointestinal surgeons, 6% vascular surgeons, and
10% others (Table 2).
Overall, less than half of the respondents appear to adhere to
the recommendations of a specific RCTwithin their field of expertise
with a median of 47% ‘‘corresponding’’ answers. However, a very
wide range of proportions of answers corresponding to adoption of
RCT recommendation was found within each of the surgical fields:
(0–73%) (Fig. 2). General surgeons showed a range of 3% to 71% to
their adoption of RCTs recommendation, colorectal surgeons from
0% to 94%, HPB from 10% to 76%, and UGI from 23% to 84%
(Table 3). Interestingly, in all fields of expertise, there were trials that
had either a rather high (> 60–65%), or a low adherence percentage
(<20–25%), indicating that the respondents were relatively consis-
tent in their opinion regarding specific RCT’s recommendations
(Table 3). In the regression analysis, none of the factors that might
explain the proportion of ‘‘corresponding’’ answers showed a sta-
tistically significant association, namely journal IF, 5-year citation
index, cohort size, results included into guidelines.
The survey tested the respondents in theirmost common reasons
for adopting a new practice. First came the availability of a RCT-
manuscript (two-thirds of respondents), followed by having assisted
the new approach in a live operation (18%), hearing a presentation by
an expert in the field (12%), and havingwatched a surgical video (4%).
None of the respondents declared not to be open for novel practices.
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Indicated reasons for not adopting a new procedure were primarily
doubts regarding the validity of the study (40%). Less than a fourth of
the respondents (24%) mentioned that the presumption of low clinical
relevance would be a motive for dismissal of the RCT finding.
Unknown long-term outcomes or fear of complications associated
with certain procedure were mentioned by 15% of the surgeons;
another 15% regarded the learning curve as a major obstacle for the
adoption of the recommended procedural change. None of the polled
surgeons regarded higher cost or disapproval of the newmethod by the
patients to constitute a reason for not adopting a recommendation from
aRCT.When asked if they had ever implemented a new technique after
only seeing the new method in a video presentation, nearly half of the
surgeons (46%) answered positively. More than half (55%) also stated
to have undertaken a new procedure after reading about it in an RCT in
the past (Table 4).
DISCUSSION
This study demonstrates the paucity of RCTs emanating
from the surgical community, and even more worrisome is the
observation that most high-level available information from those
trials recommending changes in practices is not taken into account.
FIGURE 1. Flow chart of RCT selection.
After screening 34,475 RCTs published
during the time period 2009 to 2013,
we identified 2199 trials in the field of
surgery (6.4%), which were published
in recognized journals benefiting from
an Impact Factor. Further selection
restricted the study to only comparative
technical or procedural RCTs in the
domains of general, colorectal, hepato-
biliary, upper GI, and vascular surgery,
leaving 506 eligible trials, of which 219
produced results that were statistically
different between treatment/procedure
groups. Robustness evaluation regarding
randomization and blinding using
Cochrane criteria resulted in a final delin-
eation of 112 RCTs that could be incorpo-
rated into our questionnaire.
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Less than half of the members of the ESA may adhere to the
recommendations of high-quality RCTs with, however, a large
variation among trials (0–90%) (Fig. 2) depending on the fields
examined; the field of colorectal surgery showing a slightly better
adherence to RCTs compared to the others. Surgeons regard good
RCTs as the principal reason for a change in surgical policy, but
they mitigate their enthusiasm by indicating that their outlook of
the methodology represents the main impediment precluding
adoption of a trial’s recommendations.
Only 6% of all RCTs cover a surgical topic, and reticence in
embarking in RCTmostly relies on difficulties in the standardization of
surgical techniques with the lack of equipoise justifying randomization;
this fromboth fromsurgeon and patient perspectives.22Also, blinding of
patients, health care providers, and outcome assessors to reduce bias is
not only difficult, but often impossible.23 In addition,RCTs are time- and
cost-consuming.Hence, theymaysimplybeunsuitable tounderscore the
exploration, or implementation, of novel techniques, as these can change
rapidly so that datamaybecomeof less interest to surgeons once they are
finally published.24–27 The notion that surgical practice may outrun
RCTs is illustrated by minimally invasive revolution over the past 3
decades, led by the worldwide adoption of laparoscopic cholecystec-
tomy in the early 1990s.28 Quantitative observational methods widely
used in aviation and automobile industry, such as Statistical Process
Control, as well as the IDEAL framework, provide solutions to many of
the problems inherent to RCTs and assure patient safety and quality
assessment during introduction of new technology in surgical proce-
dures.29,30 Statistical Process Control (SPC) helps in monitoring new
procedures in a predefined frame, as has been successfully shown in
manufacturing lines. It allows early detection and prevention of prob-
lems and could be transferred to the operating theater to monitor the
introduction of novel procedures in surgery.31
While the complexity of surgical RCTs has been extensively
addressed,32–35 the adoption of their results into clinical practice has
not. Here, we show that less than half of responding ESA members is
ready to accept a change of surgical policy based on a certain RCT.
This acceptance rate may be even overestimated, as the vast majority
of ESA members have positions in academia where adherence to
outcomes of clinical research might penetrate earlier, and surgical
policy might be expected to be less dominated by individual sur-
geons’ preference. This leaves room for the possibility that the actual
‘‘acceptance rate’’ of surgical RCT results in general surgical prac-
tice might even be significantly lower.
The great variation in adopting certain RCT results over all fields
of surgical specialization is interesting. Particularly, there appeared to be
hardly any ‘‘grey area’’: respondents either embraced the results of a
specific trial or refuted it. Someone can only speculate as to the causes
underlying this observation. Apparently, some trials confirm the current
practice of the individual surgeon or are considered so convincing that
the surgeon is willing to change his or her practice accordingly. Another
matter is timeliness. It has to be accepted that achieving change takes
time, and that several RCTs on the same topic producing similar
outcomes may be necessary to convince the surgical community to
change policy. This might explain the remarkably low acceptance of 2
high-quality RCT-based technical recommendations regarding pancrea-
tico-jejunostomy in Whipple’s procedure.36,37 An RCT published 2011
in Ann Surg recommended an external intrapancreatic stent in Whipple
procedures of soft pancreatic texture and a nondilated pancreatic duct.36
This recommendation was adopted by only 25% (19/76; CI 0.016–
0.36). The second example refers to the dual institutional trial published
2009 in the Journal of American College of Surgeons advocating an
invagination technique in order to reduce fistula rates by half, when
compared to the duct-to-mucosa pancreaticojejunostomy.37 Only 10%
(8/80CI: 0.05–0.19) of the responding academic surgeons have adopted
this technique (Table 3). In general, the minimally invasive surgical
techniques appear to have found widespread acceptance in surgeons’
daily practice. For example, in colorectal surgerymany RCTs published
over decades and consistently showing favorable results of laparoscopic
procedures over the open ones have finally led towidespread acceptance
and adoption of the minimal invasive approach by the surgical commu-
nity.38–44Accordingly, 85% and 94% of the responding surgeons opted
for a laparoscopic approach as their standard technique in resections for
colorectal cancer and diverticulitis, respectively.
Themain observation of this study is that clinical practice does
not seem to adapt readily to the outcomes of surgical RCTs. The most
commonly mentioned reason for nonacceptance was skepticism
regarding the validity of the applied methodology, followed by
RCT results believed to be of low clinical relevance. Indeed, RCTs
are rarely considered to reflect the ‘‘real world,’’ amongst others due
to adherence to stringent in- and exclusion criteria, affecting the
generalizability of trial outcomes.10 As an alternative, large data sets
from national registries or audits could be used to assess surgical
outcomes, which – when well conducted – may represent a more
realistic evaluation of daily surgical practice than RCTs.45 The
discovery of increased severe bile duct injuries with the introduction
of laparoscopic cholecystectomy was only possible through a well-
conducted registry and would have remained undetected in RCTs due
TABLE 1. Overview RCTs With Low Risk of Bias (n ¼ 112)
Journals (n) 15
Year of publication 2009–2013
Impact factor at time of publication, median (range) 3.1 (0.83–7.9)
RCT (n) 112
Countries of origin (n) 30
Citation Index (5 yr), median (range) 54 (3–474)
Participating centers, median (range) 1 (1–41)
Cohort size nr. of total patients, median (range) 100 (24–1000)
TABLE 2. Characteristics Survey
Respondents of survey (n) 130
Gender (male), % (n/N) 82% (107/130)
Years of experience, median (range) 16 yr (0–48)
Respondents’ specialization
General surgery, % (n/N) 27% (35/130)
Colorectal surgery, % (n/N) 22% (29/130)
HPB surgery, % (n/N) 22% (28/130)
Upper GI surgery, % (n/N) 13% (17/130)
Vascular surgery, % (n/N) 6% (8/130)
Transplant surgery, % (n/N) 6% (8/130)
Thoracic surgery, % (n/N) 1% (1/130)
Cardiac surgery, % (n/N) 1% (1/130)
Trauma surgery, % (n/N) 2% (3/130)
Journals of RCT publication (n) 15
Year of publication 2009–2013
Impact factor at time of publication, median (range) 3.3 (1.23–7.9)
RCT included in survey (n) 36
Citation Index (5 yr), median (range) 85 (24–474)
Participating centers, median (range) 1 (1–31)
Cohort size nr. of total patients, median (range) 133 (28–856)
General surg. RCT included, % (n/N) 19% (7/36)
Colorectal RCT included, % (n/N) 42% (15/36)
HPB RCT included, % (n/N) 28% (10/36)
Upper GI RCT included, % (n/N) 8% (3/36)
Vascular surgery RCT included, % (n/N) 3% (1/36)
Questions for survey (n) 22
General surg. questions, % (n/N) 27% (6/22)
Colorectal surg. questions, % (n/N) 32% (7/22)
HPB surg. questions, % (n/N) 27% (6/22)
Upper GI surg. questions, % (n/N) 9% (2/22)
Vascular surg. questions, % (n/N) 5% (1/22)
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to their small sample size. Among 34,490 cholecystectomies, an
incidence of 0% to 4% was discovered, with bile duct injuries being
10 higher in laparoscopic cholecystectomies than what was
observed with the open procedure.46
Other reasons for not implementing recommended practices
may include organizational hurdles and/or financial considerations.
One example is the recommended intraoperative rendez-vous pro-
cedure for patients with concomitant gallbladder- and common bile
duct stones, advocated by only 14/109 respondents. Also, though not
included in the present survey, RCTs favoring robotic techniques are
coming into view, but the application of robotic systems has hitherto
been hampered by significant cost-concerns in many institutions.47
On the other hand, RCT results may be met with skepticism, when
they contradict the impression or expectations of the professionals.
An interesting example is the endovascular treatment of abdominal
aneurysms: while the clinical experience is that EVAR significantly
reduces mortality and morbidity at acceptable costs, this treatment
was shown not to be cost-effective in long-term RCT follow-up
studies, and in RCTs thus far mortality rates in acute cases are not
significantly better compared to open repair.17,48 Furthermore, the
role of industry in pushing certain technology forward should be
considered as a well-established major source of bias.49
Meaningful RCTs that advocate for a change in clinical practice
should include relevant patient outcome data as primary endpoint and
be adequately powered. They need to fulfill the Cochrane criteria
including important items such as random sequence generation,
allocation concealment, blinding of participants, and personal as well
as blinding of outcome assessments. With our thorough selection
process we did include only those ‘‘robust’’ RCTs with a statistically
significant difference in results between groups to overcome equipoise
of one surgical procedure over another. Nevertheless, recommenda-
tions of those highly selected RCTs were adopted in only 47%. Forty
percent of respondents expressed doubts regarding the validity of the
methodology used in RCTs. It is this skepticism which opens a gap
between high quality, patient relevant recommendations, and the
adoption into clinical practice.
The question remains how we can increase penetrance and
adoption of recommendation generated by RCTs into clinical practice.
In a first attempt surgeons must be convinced of the surgical procedure.
This can be achieved best bymaking results visible, available to the busy
surgeon. As our survey revealed, eye-catching visual abstracts have high
potential in getting surgeons’ attention and already many journals are
becoming active on socialmedia. There is an imminent need for stronger
emphasis on video sessions as 46% of our respondents implemented a
new surgical technique after having seen a video presentation. Also,
novel ways of evaluating surgical techniques should be embraced, in
order to facilitate convincing surgeons of their value. As an example, the
method of statistical process control was recently reported by a group of
urologists to prospectively monitor patient safety during the learning
phase of robotic kidney transplantation.31
By nature, any survey suffers from shortcomings, including
possible lack of representativity/generalizability and inherent bias
regarding the questions, the selected RCTs, and the respondents’ back-
ground. Unfortunately, we were unable to identify factors that might
determine theadoptionof surgicalRCTresults.Nonetheless, it represents
a rare analysis of the impact of RCTs on daily surgical practice, inviting
FIGURE 2. Questions and ‘‘corresponding’’ answers of the pulled academic surgeons. This figure shows the wide range between
asked questions and ‘‘corresponding’’ (according to RCT recommendation) answers. If answers corresponded with RCT recom-
mendation, they are located to the right side of the graph, if not, on the left side.
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possible alternatives to RCTs in the evaluation of surgical innovation. In
addition, the assertion that almost half of the respondents have adopted a
new technique after merely seeing a video presentation gives rise to the
concern that more modern ways of distributing scientific results other
than traditional presentation at conferences and in journals should be
seriously monitored to increase surgeons’ attention novel developments
in the field at an earlier stage. Ideally, RCTs would need to be corrobo-
rated by data from registries, large cohort studies, video presentations,
and long-term and cost-effectiveness analyses, in order to enhance
acceptance of their outcomes.
In conclusion, procedural surgical RCTs are still embraced as
the highest level of surgical evidence. Nonetheless, they carry a
highly variable degree of adoption in daily surgical practice. More
emphasis should go to ways to better convince the surgical commu-
nity of the evidence produced, including modern methods of dis-
seminating RCTs outcomes, corroborating evidence from similar
RCTs, and additional tools to evaluate surgical innovations.
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DISCUSSANTS
Fabrizio Michelassi (New York, USA):
Thank you for asking me to comment on this special lecture,
which looks at the efficacy of technical or procedural randomized
control trials (RCTs) in changing current surgical practices. The
authors have concluded that surgical RCTs have a low impact on
daily surgical practice, and that the diffusion of new techniques and
modern media, such as videos, is preferred.
Randomized control trials have long been considered the gold
standard for practice-changing research. Although they have clear
benefits, such as providing direct comparisons between variables,
and limiting bias and confounders, they have many limitations as
well. Several pitfalls include the difficulty of achieving a sample size
sufficient to power the study to be statistically significant and the fact
that the cohort may not be reflective of the general population, once
inclusion and exclusion criteria have been considered. In the end, a
surgeon may not find the results applicable to their patients or
feasible to implement in their practice.
Operative videos have become a fast and inexpensive way to
share and learn novel surgical techniques. As visual learners, who are
often trained with the mantra of ‘‘see one, do one, teach one,’’ it is
unsurprising that surgeons would be willing to accept this learning
method. Junior surgeons can observe and adopt more efficient
techniques for complex scenarios or watch a video on a unique
procedure, which they may not have encountered in practice. Simi-
larly, experienced surgeons are able to observe an innovative tech-
nique by watching a video and replicating it using a learning method
that is similar to the one they used during their training.
It is interesting that when the authors asked the members of
the European Surgical Association what their most common rea-
sons for adopting a new practice are, the first reason was the
availability of a RCT in 67% of cases, underscoring the validity
of this type of trial. So, how do the authors reconcile this differ-
ence? Is it possible that surgeons, who are cautious of deviating
from standard and proven practices, require more than just one
single result to change their techniques? Is it possible that changing
practice will continue to require a combination of different
evidence: randomized clinical trials; analysis; and discussions,
such as the ones we have had here for the past two days over social
media and other diffusion modalities?
Thank you for the honor to discuss this special lecture presen-
tation.
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Response From Christian Oberkofler (Zurich,
Switzerland):
Professor Michelassi, thank you very much for your thought-
ful comments. While the hurdles and barriers of surgical RCTs are
well known and have been experienced by many of us, the adoption
of their results into clinical practice has never been investigated so
far. Here, for the very first time, we present an analysis on possible
reasons why recommendations of RCTs find their way into the
adoption of a clinical practice or not. As you mentioned, surgeons
are prone to be visual learners, and therefore, our findings on the high
impact of visual abstracts and videos on the clinical adoption of a
new surgical procedure are somehow intuitively expected.
Nevertheless, RCTs are still perceived as the gold standard of
clinical research. This fact may have led to the logical answer of ESA
members as per their most common reason for adopting a new
practice: the availability of an RCT.
As I presented, there is a gap between meaningful recom-
mendations drawn from academic clinical research and the clinical
adoption of these recommendations into daily practice. Looking at
the results of our survey, this gap is larger than expected and the
future challenge our surgical community has to undertake is to close
this gap by selling our RCTs better. Social media, such as Twitter,
Facebook, and LinkedIn, could play an important role in this.
I do agree with your statement that one RCT alone may
generally be insufficient to overcome the skepticism of experienced
surgeons, who have developed their practice into one that they have
become confident with over many years. This may be why the
minimal invasive approach in colorectal surgery is now widely
accepted, after more than 3 decades of repeated RCTs showing
the favorable results of laparoscopic procedures over the open ones.
Thanks again for your valuable comments.
Han-Kwang Yang (Seoul, Republic of Korea):
The value of this study would be a rare analysis of the impact
of RCTs on daily surgical practice.
The common adoption of a new surgical technique or surgical
decision is based on a treatment guideline. The guideline is formu-
lated by the sum of all of the evidence, including the RCT. One good
RCT is not necessarily directly reflected in the guideline. That could
explain why even academic ESA surgeons in this survey adopt only
half of the RCT results.
The issues of accepting a new surgical procedure as standard
and properly executing a new surgical procedure are different.
In this sense, the authors’ question as to whether the RCT, live
surgery assistant or act of watching a video, in order to adopt a new
surgical procedure, does not look appropriate.
I hope that this study result does not discourage the value of
surgical RCTs.
Rather, I would like to suggest that authors discuss the
following points:
First, how to design good surgical clinical study RCTs (vs.
6%)?
Second, how to define good RCTs, which may affect my
practice?
Third, workshop videos or hands on to help the learning
curve?
Finally, the authors suggest that there are ‘‘alternative methods
of evaluating and monitoring surgical procedures, such as those
available in the aviation and automobile industry’’ (ie, the Statistical
Process Control or SPC). Obviously, these kinds of approaches need
to be tested in many cases, in order to draw valuable conclusions.
How about the concern about the balance between well-defined
RCTs with limited patients versus thousands of patients? In addition,
in contrast to the other industries, each case may not be as simple to
compare. Are there any examples of SPC in the field of surgery?
Response From Christian Oberkofler (Zurich,
Switzerland):
Thank you Professor Yang, it is a great honor to have your
input on our analysis of the adoption of surgical procedural RCTs in
daily clinical practice. A single well-conducted RCT is certainly the
best way to produce valid evidence on the effectiveness of inter-
ventions and can overcome equipoise. In this context, following
RCTs can also be seen as ethically doubtful, as equipoise is not given
anymore. Therefore, in my opinion, a ‘‘high quality’’ RCT should
trigger a change in clinical practice.
With our survey, we did not intend to temper the value
of surgical RCTs, but rather draw attention to the gap between
high-quality patient relevant recommendations and daily clinical
practice.
With regards to your first question, good surgical clinical study
RCTs need to have a relevant patient outcome as the primary endpoint
as well as respect the Cochrane criteria of conducting RCTs.
Regarding your second question, we did try to answer this
question in our survey, including only well-designed, ‘‘good’’ RCTs.
Unfortunately, in our regression analysis, we were unable to correlate
any factor favoring the adoption into clinical practice.
Concerning your third question, it is our perception that video
workshops and hands on training do find a broad acceptance within
the surgical community, and in my opinion, they will become
increasingly important to convey novel techniques and approaches.
Finally, SPC has been described for the evaluation of novel
surgical procedures in the literature. The main reason for us to
propose such a methodology is to use preset criteria and limitations
during the evaluation, that is before the implementation of a
new technique.
Arnulf Hölscher (Frankfurt, Germany):
First, 40% of the respondents indicated doubts regarding the
validity of the study as a reason for not adopting a new procedure.
Could you explain the reasons for these doubts a bit more?
Second, nearly 1 quarter of the respondents named low clinical
relevance as a reason for the dismissal of the RCT findings.Was there
a higher rate of adoption for the results of the RCTs with obviously
high clinical relevance?
Response From Christian Oberkofler (Zurich,
Switzerland):
Thank you Professor Hölscher, it is a great honor to have you
as a discussant of our survey.
Indeed, 40% of the respondents did not adopt a new surgical
procedure, due to their skepticism regarding the validity of the method-
ology of the RCTs. As we did not ask respondents on their reasons of
mistrust against RCTs, I can only speculate. Surgeons still learn their
craft through apprenticeship. They stick to their own experience and
become comfortable with a specific procedure, and therefore, they may
initially express skepticism toward novel techniques.
In our linear regression model, we aimed to find a correlation
between factors of an RCT and their adoption into clinical practice.
Our highly selected RCTs all have clinically relevant outcomes, but it
was demonstrated that their recommendations still had a relatively
low adoption rate.
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